These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 28341030)

  • 1. The clinical value of hepatic extracellular volume fraction using routine multiphasic contrast-enhanced liver CT for staging liver fibrosis.
    Guo SL; Su LN; Zhai YN; Chirume WM; Lei JQ; Zhang H; Yang L; Shen XP; Wen XX; Guo YM
    Clin Radiol; 2017 Mar; 72(3):242-246. PubMed ID: 28341030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimation of hepatic extracellular volume fraction using multiphasic liver computed tomography for hepatic fibrosis grading.
    Yoon JH; Lee JM; Klotz E; Jeon JH; Lee KB; Han JK; Choi BI
    Invest Radiol; 2015 Apr; 50(4):290-6. PubMed ID: 25493416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic and pancreatic extracellular volume fraction analysis using contrast-enhanced CT in patients with diabetes mellitus and pre-diabetes.
    Fukui H; Onishi H; Nakamoto A; Tsuboyama T; Ota T; Honda T; Kiso K; Yoshidome E; Enchi Y; Tatsumi M; Tomiyama N
    Jpn J Radiol; 2024 Jun; 42(6):599-611. PubMed ID: 38351253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accuracy of Liver Surface Nodularity Quantification on MDCT as a Noninvasive Biomarker for Staging Hepatic Fibrosis.
    Pickhardt PJ; Malecki K; Kloke J; Lubner MG
    AJR Am J Roentgenol; 2016 Dec; 207(6):1194-1199. PubMed ID: 27575867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and Validation of a Deep Learning System for Staging Liver Fibrosis by Using Contrast Agent-enhanced CT Images in the Liver.
    Choi KJ; Jang JK; Lee SS; Sung YS; Shim WH; Kim HS; Yun J; Choi JY; Lee Y; Kang BK; Kim JH; Kim SY; Yu ES
    Radiology; 2018 Dec; 289(3):688-697. PubMed ID: 30179104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study on diagnostic value of extracellular volume imaging by magnetic resonance imaging for liver fibrosis of hepatitis B].
    Sheng RF; Jin KP; Wang HQ; Ji Y; Chen CZ; Zeng MS
    Zhonghua Gan Zang Bing Za Zhi; 2018 Sep; 26(9):650-653. PubMed ID: 30481860
    [No Abstract]   [Full Text] [Related]  

  • 7. Liver fibrosis assessment with multiphasic dual-energy CT: diagnostic performance of iodine uptake parameters.
    Nagayama Y; Kato Y; Inoue T; Nakaura T; Oda S; Kidoh M; Ikeda O; Hirai T
    Eur Radiol; 2021 Aug; 31(8):5779-5790. PubMed ID: 33768289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CT texture analysis of the liver for assessing hepatic fibrosis in patients with hepatitis C virus.
    Lubner MG; Jones D; Kloke J; Said A; Pickhardt PJ
    Br J Radiol; 2019 Jan; 92(1093):20180153. PubMed ID: 30182750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver Fibrosis: Deep Convolutional Neural Network for Staging by Using Gadoxetic Acid-enhanced Hepatobiliary Phase MR Images.
    Yasaka K; Akai H; Kunimatsu A; Abe O; Kiryu S
    Radiology; 2018 Apr; 287(1):146-155. PubMed ID: 29239710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy Analysis of Double-Low Dynamic Contrast-Enhanced CT and Hepatic Extracellular Volume Fraction in the Diagnosis of Liver Fibrosis.
    Liang Z; Liu Y; Nie Y
    Contrast Media Mol Imaging; 2022; 2022():8089914. PubMed ID: 36072627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An elevated arterial enhancement fraction is associated with clinical and imaging indices of liver fibrosis and cirrhosis.
    Bonekamp D; Bonekamp S; Geiger B; Kamel IR
    J Comput Assist Tomogr; 2012; 36(6):681-9. PubMed ID: 23192205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of liver fibrosis in rats by MRI with apparent diffusion coefficient and T1 relaxation time in the rotating frame.
    Hu G; Zhang X; Liang W; Zhong X; Chan Q; Lin X; Lin T; Li Y; Quan X
    J Magn Reson Imaging; 2016 May; 43(5):1082-9. PubMed ID: 26497954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Liver Segmental Volume Ratio for Noninvasive Detection of Cirrhosis: Comparison With Established Linear and Volumetric Measures.
    Furusato Hunt OM; Lubner MG; Ziemlewicz TJ; Muñoz Del Rio A; Pickhardt PJ
    J Comput Assist Tomogr; 2016; 40(3):478-84. PubMed ID: 26966951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of intravoxel incoherent motion in detecting and staging liver fibrosis: A meta-analysis.
    Ye Z; Wei Y; Chen J; Yao S; Song B
    World J Gastroenterol; 2020 Jun; 26(23):3304-3317. PubMed ID: 32684744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver Surface Nodularity Quantification from Routine CT Images as a Biomarker for Detection and Evaluation of Cirrhosis.
    Smith AD; Branch CR; Zand K; Subramony C; Zhang H; Thaggard K; Hosch R; Bryan J; Vasanji A; Griswold M; Zhang X
    Radiology; 2016 Sep; 280(3):771-81. PubMed ID: 27089026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamic contrast-enhanced MRI with Gd-EOB-DTPA for the quantitative assessment of early-stage liver fibrosis induced by carbon tetrachloride in rabbits.
    Liu HF; Wang Q; Du YN; Zhu ZH; Li YF; Zou LQ; Xing W
    Magn Reson Imaging; 2020 Jul; 70():57-63. PubMed ID: 32325235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative imaging: quantification of liver shape on CT using the statistical shape model to evaluate hepatic fibrosis.
    Hori M; Okada T; Higashiura K; Sato Y; Chen YW; Kim T; Onishi H; Eguchi H; Nagano H; Umeshita K; Wakasa K; Tomiyama N
    Acad Radiol; 2015 Mar; 22(3):303-9. PubMed ID: 25491738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic enhancement in multiphasic contrast-enhanced MDCT: comparison of high- and low-iodine-concentration contrast medium in same patients with chronic liver disease.
    Furuta A; Ito K; Fujita T; Koike S; Shimizu A; Matsunaga N
    AJR Am J Roentgenol; 2004 Jul; 183(1):157-62. PubMed ID: 15208131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison between CT volumetry and extracellular volume fraction using liver dynamic CT for the predictive ability of liver fibrosis in patients with hepatocellular carcinoma.
    Tago K; Tsukada J; Sudo N; Shibutani K; Okada M; Abe H; Ibukuro K; Higaki T; Takayama T
    Eur Radiol; 2022 Nov; 32(11):7555-7565. PubMed ID: 35593960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computed Tomography-Derived Extracellular Volume Fraction and Splenic Size for Liver Fibrosis Staging.
    Kutaiba N; Tran A; Ashraf S; Con D; Lokan J; Goodwin M; Testro A; Egan G; Lim R
    J Comput Assist Tomogr; 2024 Nov-Dec 01; 48(6):837-843. PubMed ID: 38858799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.